Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Evaluate efficacy of GED-0301 at Week 12, administered as either a single 160 mg tablet or as four 40 mg tablets, compared with placebo on clinical activity in subjects with active CD
Critère d'inclusion
- Active Crohn's disease